ChemoCentryx Receives $29,840,000 Series D Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    850 Maude Avenue Mountain View, CA 94043
  • Company Description
    ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Alta Partners
  • Venture Investor
  • Venture Investor
    HBM Bioventures
  • Venture Investor